|
|
The predictive value of blood gas parameters on curative effect and prognosis of neonatal pneumonia treated with high-flow nasal catheter |
DUAN Guangmin, ZHAO Jing, FU Xiaomei |
Department of Pediatrics, First People's Hospital of Neijiang, Neijiang 641000, China |
|
|
Abstract Objective To investigate the effect and predictors of failure of high-flow nasal cannula (HFNC) as the primary respiratory support therapy for non-invasive ventilation in severe neonatal pneumonia (NSP). Methods This study retrospectively analyzed 85 neonates with NSP admitted to the neonatal intensive care unit of our hospital from January 2019 to December 2021. All patients received HFNC as primary supportive care. HFNC failure was defined as the need for escalation to noninvasive ventilation or invasive mechanical ventilation. Based on clinical data obtained before HFNC treatment and at 30, 60, 120, and 720 min after treatment, HFNC success (responders) and HFNC failure groups (non-responders) were compared. Results Among 85 neonatal infants, 13 patients (15.29%, 13/85) experienced HFNC failure, and 72 patients (84.71%, 72/85) were successfully ventilated. Compared with the failed HFNC group, the gestational age, birth weight, and duration of HFNC in the successful HFNC group were significantly increased, as well as the respiratory distress score and the length of hospital stay were significantly decreased. The comparison of baseline gas and blood parameters showed that the RS of the successful HFNC group was significantly lower than that of the failed HFNC group, and the SpO2/FiO2 (S/F), SpO2 and pH were significantly increased. Gestational age, severity of respiratory distress, RS and S/F predicted HFNC failure according to logistic regression analysis. After HFNC treatment, RR, HR, RS and FiO2 were significantly decreased in both groups, and SpO2 and S/F ratio were increased. Compared with the successful HFNC group, the HFNC failure group had significantly lower RS and FiO2 after HFNC treatment, and increased SpO2 and S/F ratio. The achievement rate of S/F goals at 30 min and 60 minutes, RR goals at 30 minutes, and RS goals at 30 minutes was higher in the HFNC success group compared with the HFNC failure group. In logistic regression analysis, the 60-min S/F target significantly predicted successful HFNC treatment (OR=8.035, 95%CI 2.980-21.658). Conclusions HFNC is suitable for the treatment of respiratory distress/failure of NSP newborns, and S/F ratio can be used as an early warning index to monitor the failure of treatment before or 60 minutes after HFNC treatment.
|
Received: 11 July 2023
|
|
|
|
[1] 单丽琴, 周庆女, 黄华飞. 有创-无创序贯机械通气治疗新生儿重症肺炎伴呼吸衰竭的疗效观察[J]. 浙江医学, 2020, 42(2): 181-183. [2] 邓云森, 李盛强, 林丽妮, 等. 血清25- (OH) D, hs-CRP, PCT与新生儿重症肺炎的关系研究[J]. 中国急救复苏与灾害医学杂志, 2020, 15(1): 75-77. [3] 谢朝云, 蒙桂鸾, 熊芸, 等. 新生儿重症监护病房中重症肺炎多种菌感染相关因素分析[J]. 临床儿科杂志, 2020, 38(4): 260-263. [4] 陈倩倩, 徐秀小, 李跃. 精细化护理在新生儿重症肺炎合并呼吸衰竭护理中的应用观察[J]. 重庆医学, 2020, 49(S01): 408-410. [5] 杨文娜, 张琳. 保守氧疗法在重症肺炎机械通气患者中的应用效果观察[J]. 中华危重病急救医学, 2021, 33(9): 1069-1073. [6] FAINARDI V, ABELLI L, MUSCARÀ M, et al.Update on the role of high-flow nasal cannula in infants with bronchiolitis[J]. Children, 2021, 8(2): 66. [7] CONTE F, ORFEO L, GIZZI C, et al.Rapid systematic review shows that using a high-flow nasal cannula is inferior to nasal continuous positive airway pressure as first-line support in preterm neonates[J]. Acta Paediatr, 2018, 107(10): 1684-1696. [8] CANNING A, FAIRHURST R, CHAUHAN M, et al.Oral feeding for infants and children receiving nasal continuous positive airway pressure and high-flow nasal cannula respiratory supports: a survey of practice[J]. BMC Pediatr, 2021, 21: 83. [9] OKTEM A, YIGIT S, OĞUZ B, et al. Accuracy of lung ultrasonography in the diagnosis of respiratory distress syndrome in newborns[J]. J Matern Fetal Neonatal Med, 2021, 34(2): 281-286. [10] ŞIK N, ŞENOL H B, ÇAĞLAR A, et al. Early application of non-invasive ventilation for children with pulmonary edema after drowning[J]. Pediatr Int, 2022, 64(1): e14858. [11] LUO J, DUKE T, CHISTI M J, et al. Efficacy of high-flow nasal cannula vs standard oxygen therapy or nasal continuous positive airway pressure in children with respiratory distress: a meta-analysis[J]. J Pediatr, 2019, 215: 199-208. e8. [12] PAPOFF P, CARESTA E, LUCIANI S, et al.The starting rate for high-flow nasal cannula oxygen therapy in infants with bronchiolitis: Is clinical judgment enough?[J]. Pediatr Pulmonol, 2021, 56(8): 2611-2620. [13] YILDIZDAS D, YONTEM A, IPLIK G, et al.Predicting nasal high-flow therapy failure by pediatric respiratory rate-oxygenation index and pediatric respiratory rate-oxygenation index variation in children[J]. Eur J Pediatr, 2021, 180(4): 1099-1106. [14] ROCA O, CARALT B, MESSIKA J, et al.An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy[J]. Am J Respir Crit Care Med, 2019, 199(11): 1368-1376. [15] KIM G E, CHOI S H, PARK M, et al.SpO2/FiO2 as a predictor of high flow nasal cannula outcomes in children with acute hypoxemic respiratory failure[J]. Sci Rep, 2021, 11(1): 13439. [16] SLATER A, STRANEY L, ALEXANDER J, et al.The effect of imputation of PaO2/FiO2 from SpO2/FiO2 on the performance of the pediatric index of mortality 3[J]. Pediatr Crit Care Med, 2020, 21(6): 520-525. [17] RAY S, ROGERS L, PAGEL C, et al.PaO2/FiO2 ratio derived from the SpO2/FiO2 ratio to improve mortality prediction using the pediatric index of mortality-3 score in transported intensive care admissions[J]. Pediatr Crit Care Med, 2017, 18(3): e131-e136. [18] Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5): 428-439. [19] EMERIAUD G, NAPOLITANO N, POLIKOFF L, et al.Impact of failure of noninvasive ventilation on the safety of pediatric tracheal intubation[J]. Crit Care Med, 2020, 48(10): 1503-1512. |
[1] |
HUANG Fengmei, HE Chun, YU Xiaoli, PENG Huabao, HOU ZhangHua, TAN Ruokun, ZHU Lihui. Effects of non-invasive ventilation combined with shenfu injection on lung function, immune function, PCT, IL-17 and CRP in children with severe asthma complicated with respiratory failure[J]. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(3): 66-70. |
|
|
|
|